candesartan cilexetil 8 MG Oral Tablet

RxCUI
153823
RxNorm name
candesartan cilexetil 8 MG Oral Tablet
Display name
candesartan cilexetil 8 MG Oral Tablet
Full name
candesartan cilexetil 8 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Candesartan cilexetilCANDESARTAN CILEXETILGolden State Medical Supply, Inc.15601654-76da-04cf-e063-6394a90a2cb52026-01-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 153823
Candesartan cilexetilCANDESARTAN CILEXETILZydus Lifesciences Limited26df3269-3682-4ce0-be81-8c029254b5a82025-12-24Exact identifier
rxcui: 153823
ATACANDCANDESARTAN CILEXETILANI Pharmaceuticals, Inc.94a59260-d2b6-464a-b5b9-bbc599e57e102025-12-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 153823
Candesartan cilexetilCANDESARTAN CILEXETILANI Pharmaceuticals, Inc.4621249c-1f44-4d95-8513-a1a2b1859e412025-12-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 153823
CANDESARTAN CILEXETILCANDESARTAN CILEXETILAlembic Pharmaceuticals Limitedd5b43fa0-6678-4219-99f1-10d273d49baf2023-01-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 153823
CandesartanCANDESARTANMacleods Pharmaceuticals Limited8ceb5658-b03c-475d-9ef0-2cd0645191d32022-12-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 153823
CANDESARTAN CILEXETILCANDESARTAN CILEXETILAlembic Pharmaceuticals Inc.8a515af5-bd53-43f1-b40a-aa0f332bc2ab2021-09-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 153823
candesartan cilexetilCANDESARTAN CILEXETILMylan Pharmaceuticals Inc.904b357e-97bf-475e-90a5-f0449f2a428e2021-05-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 153823

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 10 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8ceb5658-b03c-475d-9ef0-2cd0645191d3candesartan cilexetil 8 MG Oral Tablet [PSN] · candesartan cilexetil 8 MG Oral Tablet [SCD]26These highlights do not include all the information needed to use CANDESARTAN CILEXETIL TABLETS safely and effectively. See full prescribing information for CANDESARTAN CILEXETIL TABLETS. CANDESARTAN CILEXETIL tablets, for oral use Initial U.S. Approval: 199820221228
8a515af5-bd53-43f1-b40a-aa0f332bc2abcandesartan cilexetil 8 MG Oral Tablet [PSN] · candesartan cilexetil 8 MG Oral Tablet [SCD]26These highlights do not include all the information needed to use CANDESARTAN CILEXETIL TABLETS safely and effectively. See full prescribing information for CANDESARTAN CILEXETIL TABLETS. CANDESARTAN CILEXETIL tablets, for oral use Initial U.S. Approval: 199820210930
26df3269-3682-4ce0-be81-8c029254b5a8candesartan cilexetil 8 MG Oral Tablet [PSN] · candesartan cilexetil 8 MG Oral Tablet [SCD]25CANDESARTAN CILEXETIL TABLETS20251224
94a59260-d2b6-464a-b5b9-bbc599e57e10candesartan cilexetil 8 MG Oral Tablet [PSN] · candesartan cilexetil 8 MG Oral Tablet [SCD]25These highlights do not include all the information needed to use ATACAND safely and effectively. See full prescribing information for ATACAND. ATACAND ® (candesartan cilexetil) tablets, for oral use Initial U.S. Approval: 199820251222
d5b43fa0-6678-4219-99f1-10d273d49bafcandesartan cilexetil 8 MG Oral Tablet [PSN] · candesartan cilexetil 8 MG Oral Tablet [SCD]24These highlights do not include all the information needed to use CANDESARTAN CILEXETIL TABLETS safely and effectively. See full prescribing information for CANDESARTAN CILEXETIL TABLETS. CANDESARTAN CILEXETIL tablets, for oral use INITIAL U.S. APPROVAL: 199820230127
904b357e-97bf-475e-90a5-f0449f2a428ecandesartan cilexetil 8 MG Oral Tablet [PSN] · candesartan cilexetil 8 MG Oral Tablet [SCD]24These highlights do not include all the information needed to use CANDESARTAN CILEXETIL TABLETS safely and effectively. See full prescribing information for CANDESARTAN CILEXETIL TABLETS . CANDESARTAN CILEXETIL tablets, for oral use Initial U.S. Approval: 199820210512
fd676896-5f5b-48da-becc-3736a6fc1f14candesartan cilexetil 8 MG Oral Tablet [PSN] · candesartan cilexetil 8 MG Oral Tablet [SCD]23These highlights do not include all the information needed to use ATACAND safely and effectively. See full prescribing information for ATACAND. ATACAND ® (candesartan cilexetil) tablets, for oral use Initial U.S. Approval: 199820160806
07b7d9af-75db-4593-817a-a2543145233ccandesartan cilexetil 8 MG Oral Tablet [PSN] · candesartan cilexetil 8 MG Oral Tablet [SCD]23These highlights do not include all the information needed to use ATACAND safely and effectively. See full prescribing information for ATACAND. ATACAND ® (candesartan cilexetil) TABLETS INITIAL U.S. APPROVAL: 199820130812
15601654-76da-04cf-e063-6394a90a2cb5candesartan cilexetil 8 MG Oral Tablet [PSN] · candesartan cilexetil 8 MG Oral Tablet [SCD]22CANDESARTAN CILEXETIL TABLETS. These highlights do not include all the information needed to use CANDESARTAN CILEXETIL TABLETS safely and effectively. See full prescribing information for CANDESARTAN CILEXETIL TABLETS. CANDESARTAN CILEXETIL tablets, for oral use Initial U.S. Approval: 199820260115
4621249c-1f44-4d95-8513-a1a2b1859e41candesartan cilexetil 8 MG Oral Tablet [PSN] · candesartan cilexetil 8 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use CANDESARTAN CILEXETIL TABLETS safely and effectively. See full prescribing information for CANDESARTAN CILEXETIL TABLETS. CANDESARTAN CILEXETIL tablets, for oral use Initial U.S. Approval: 199820251222